We are analyzing https://link.springer.com/article/10.1007/s12012-011-9109-z.

Title:
Angiotensin II Infusion–Induced Inflammation, Monocytic Fibroblast Precursor Infiltration, and Cardiac Fibrosis are Pressure Dependent | Cardiovascular Toxicology
Description:
The activated renin–angiotensin–aldosterone system increases blood pressure and intracellular signals, thus leading to cardiac fibrosis. Whether increased blood pressure or angiotensin II-activated signaling is responsible for elevated angiotensin II–induced cardiac remodeling is unknown. Here, we aimed to determine whether lowering blood pressure with hydralazine might prevent inflammation and cardiac fibrosis in response to angiotensin II. We used the C57/BL6 mouse model of angiotensin II infusion (1,500 ng/kg per minute) for 7 days; 40 male mice (6 weeks old) were randomly assigned to 4 groups for treatment: mice with angiotensin II or vehicle infusion were given hydralazine in drinking water (250 mg/l per day). Heart sections were stained with hematoxylin and eosin and Masson trichrome and examined by immunohistostaining. The levels of proinflammatory cytokines were measured by real-time PCR and western blot analysis. The blood pressure of the control group began to increase on day 4 of angiotensin II infusion, and hydralazine treatment prevented angiotensin II–induced hypertension. Compared with the control, hydralazine treatment to lower blood pressure blocked angiotensin II–induced fibrosis and reduced Mac-2+ inflammatory cell infiltration and proinflammatory cytokine expression. The accumulation of blood-borne CD45+ cells and α-smooth muscle actin-positive myofibroblasts was also significantly reduced. Our results indicate that elevated blood pressure is essential for inflammatory cell infiltration and myofibroblast formation, which contribute to angiotensin II infusion–induced cardiac fibrosis. Hydralazine treatment attenuates cardiac fibrosis in response to angiotensin II. Lowering pressure could be an effective therapeutic target for cardiac fibrosis.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Science
Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

article, google, scholar, cas, pubmed, angiotensin, hypertension, cardiac, journal, fibrosis, research, inflammation, vascular, role, pressure, cardiovascular, cheng, blood, heart, physiology, system, iiinduced, remodeling, hydralazine, circulation, factor, hypertrophy, american, privacy, cookies, inflammatory, cell, cells, muscle, receptor, zhang, content, publish, search, fibroblast, infiltration, signaling, infusion, mice, treatment, increase, myofibroblast, access, renal, reninangiotensin,

Topics {✒️}

receptor-mediated p-selectin upregulation deoxycorticosterone/salt-induced cardiac fibrosis angiotensin-ii-induced cardiac hypertrophy month download article/chapter yunfei bian & chuanshi xiao angiotensin ii-activated signaling angiotensin ii-induced cardiac angiotensin ii-dependent proliferation pressure-induced renal injury angiotensin ii-induced hypertension angiotensin-converting enzyme inhibitors blood-borne cd45+ cells angiotensin-converting-enzyme inhibition transforming growth factor-beta1 c57/bl6 mouse model angiotensin ii infusion remodeling-related cardiovascular diseases elevated blood pressure increased blood pressure cardiac angiotensin ii full article pdf renin angiotensin system renin-angiotensin system cardiac hypertrophy induced privacy choices/manage cookies growth factor-1 receptor nuclear factor-kappab vascular smooth muscle nature reviews immunology inflammatory cell infiltration remodeling postmyocardial infarction lowering blood pressure target organ damage reactive myocardial fibrosis cardiac pressure overload blood vessel diseases pressure dependent published doca-salt hypertension experimental model rats remodeling induced european economic area real-time pcr effective therapeutic target nitric oxide collagen production counter regulatory actions capital medical university angiotensin ii vascular inflammation produced article qi

Questions {❓}

Cardiac angiotensin II: Does it have a function?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Angiotensin II Infusion–Induced Inflammation, Monocytic Fibroblast Precursor Infiltration, and Cardiac Fibrosis are Pressure Dependent
         description:The activated renin–angiotensin–aldosterone system increases blood pressure and intracellular signals, thus leading to cardiac fibrosis. Whether increased blood pressure or angiotensin II-activated signaling is responsible for elevated angiotensin II–induced cardiac remodeling is unknown. Here, we aimed to determine whether lowering blood pressure with hydralazine might prevent inflammation and cardiac fibrosis in response to angiotensin II. We used the C57/BL6 mouse model of angiotensin II infusion (1,500 ng/kg per minute) for 7 days; 40 male mice (6 weeks old) were randomly assigned to 4 groups for treatment: mice with angiotensin II or vehicle infusion were given hydralazine in drinking water (250 mg/l per day). Heart sections were stained with hematoxylin and eosin and Masson trichrome and examined by immunohistostaining. The levels of proinflammatory cytokines were measured by real-time PCR and western blot analysis. The blood pressure of the control group began to increase on day 4 of angiotensin II infusion, and hydralazine treatment prevented angiotensin II–induced hypertension. Compared with the control, hydralazine treatment to lower blood pressure blocked angiotensin II–induced fibrosis and reduced Mac-2+ inflammatory cell infiltration and proinflammatory cytokine expression. The accumulation of blood-borne CD45+ cells and α-smooth muscle actin-positive myofibroblasts was also significantly reduced. Our results indicate that elevated blood pressure is essential for inflammatory cell infiltration and myofibroblast formation, which contribute to angiotensin II infusion–induced cardiac fibrosis. Hydralazine treatment attenuates cardiac fibrosis in response to angiotensin II. Lowering pressure could be an effective therapeutic target for cardiac fibrosis.
         datePublished:2011-03-04T00:00:00Z
         dateModified:2011-03-04T00:00:00Z
         pageStart:157
         pageEnd:167
         sameAs:https://doi.org/10.1007/s12012-011-9109-z
         keywords:
            Hypertension
            Inflammation
            Hydralazine
            Cardiac remodeling
            Angiotensin II
            Pharmacology/Toxicology
            Cardiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12012-011-9109-z/MediaObjects/12012_2011_9109_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12012-011-9109-z/MediaObjects/12012_2011_9109_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12012-011-9109-z/MediaObjects/12012_2011_9109_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12012-011-9109-z/MediaObjects/12012_2011_9109_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12012-011-9109-z/MediaObjects/12012_2011_9109_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12012-011-9109-z/MediaObjects/12012_2011_9109_Fig6_HTML.gif
         isPartOf:
            name:Cardiovascular Toxicology
            issn:
               1559-0259
               1530-7905
            volumeNumber:11
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Humana Press Inc
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Guanming Qi
               affiliation:
                     name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
                     address:
                        name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lixin Jia
               affiliation:
                     name:The Second Hospital of Shanxi Medical University
                     address:
                        name:Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yulin Li
               affiliation:
                     name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
                     address:
                        name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yunfei Bian
               affiliation:
                     name:The Second Hospital of Shanxi Medical University
                     address:
                        name:Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jizhong Cheng
               affiliation:
                     name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
                     address:
                        name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Huihua Li
               affiliation:
                     name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
                     address:
                        name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chuanshi Xiao
               affiliation:
                     name:The Second Hospital of Shanxi Medical University
                     address:
                        name:Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jie Du
               affiliation:
                     name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
                     address:
                        name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Angiotensin II Infusion–Induced Inflammation, Monocytic Fibroblast Precursor Infiltration, and Cardiac Fibrosis are Pressure Dependent
      description:The activated renin–angiotensin–aldosterone system increases blood pressure and intracellular signals, thus leading to cardiac fibrosis. Whether increased blood pressure or angiotensin II-activated signaling is responsible for elevated angiotensin II–induced cardiac remodeling is unknown. Here, we aimed to determine whether lowering blood pressure with hydralazine might prevent inflammation and cardiac fibrosis in response to angiotensin II. We used the C57/BL6 mouse model of angiotensin II infusion (1,500 ng/kg per minute) for 7 days; 40 male mice (6 weeks old) were randomly assigned to 4 groups for treatment: mice with angiotensin II or vehicle infusion were given hydralazine in drinking water (250 mg/l per day). Heart sections were stained with hematoxylin and eosin and Masson trichrome and examined by immunohistostaining. The levels of proinflammatory cytokines were measured by real-time PCR and western blot analysis. The blood pressure of the control group began to increase on day 4 of angiotensin II infusion, and hydralazine treatment prevented angiotensin II–induced hypertension. Compared with the control, hydralazine treatment to lower blood pressure blocked angiotensin II–induced fibrosis and reduced Mac-2+ inflammatory cell infiltration and proinflammatory cytokine expression. The accumulation of blood-borne CD45+ cells and α-smooth muscle actin-positive myofibroblasts was also significantly reduced. Our results indicate that elevated blood pressure is essential for inflammatory cell infiltration and myofibroblast formation, which contribute to angiotensin II infusion–induced cardiac fibrosis. Hydralazine treatment attenuates cardiac fibrosis in response to angiotensin II. Lowering pressure could be an effective therapeutic target for cardiac fibrosis.
      datePublished:2011-03-04T00:00:00Z
      dateModified:2011-03-04T00:00:00Z
      pageStart:157
      pageEnd:167
      sameAs:https://doi.org/10.1007/s12012-011-9109-z
      keywords:
         Hypertension
         Inflammation
         Hydralazine
         Cardiac remodeling
         Angiotensin II
         Pharmacology/Toxicology
         Cardiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12012-011-9109-z/MediaObjects/12012_2011_9109_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12012-011-9109-z/MediaObjects/12012_2011_9109_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12012-011-9109-z/MediaObjects/12012_2011_9109_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12012-011-9109-z/MediaObjects/12012_2011_9109_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12012-011-9109-z/MediaObjects/12012_2011_9109_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12012-011-9109-z/MediaObjects/12012_2011_9109_Fig6_HTML.gif
      isPartOf:
         name:Cardiovascular Toxicology
         issn:
            1559-0259
            1530-7905
         volumeNumber:11
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Humana Press Inc
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Guanming Qi
            affiliation:
                  name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
                  address:
                     name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lixin Jia
            affiliation:
                  name:The Second Hospital of Shanxi Medical University
                  address:
                     name:Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yulin Li
            affiliation:
                  name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
                  address:
                     name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yunfei Bian
            affiliation:
                  name:The Second Hospital of Shanxi Medical University
                  address:
                     name:Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jizhong Cheng
            affiliation:
                  name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
                  address:
                     name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Huihua Li
            affiliation:
                  name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
                  address:
                     name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chuanshi Xiao
            affiliation:
                  name:The Second Hospital of Shanxi Medical University
                  address:
                     name:Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jie Du
            affiliation:
                  name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
                  address:
                     name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cardiovascular Toxicology
      issn:
         1559-0259
         1530-7905
      volumeNumber:11
Organization:
      name:Humana Press Inc
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
      address:
         name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
         type:PostalAddress
      name:The Second Hospital of Shanxi Medical University
      address:
         name:Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, China
         type:PostalAddress
      name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
      address:
         name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
         type:PostalAddress
      name:The Second Hospital of Shanxi Medical University
      address:
         name:Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, China
         type:PostalAddress
      name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
      address:
         name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
         type:PostalAddress
      name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
      address:
         name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
         type:PostalAddress
      name:The Second Hospital of Shanxi Medical University
      address:
         name:Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, China
         type:PostalAddress
      name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
      address:
         name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Guanming Qi
      affiliation:
            name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
            address:
               name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
               type:PostalAddress
            type:Organization
      name:Lixin Jia
      affiliation:
            name:The Second Hospital of Shanxi Medical University
            address:
               name:Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, China
               type:PostalAddress
            type:Organization
      name:Yulin Li
      affiliation:
            name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
            address:
               name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
               type:PostalAddress
            type:Organization
      name:Yunfei Bian
      affiliation:
            name:The Second Hospital of Shanxi Medical University
            address:
               name:Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, China
               type:PostalAddress
            type:Organization
      name:Jizhong Cheng
      affiliation:
            name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
            address:
               name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
               type:PostalAddress
            type:Organization
      name:Huihua Li
      affiliation:
            name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
            address:
               name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
               type:PostalAddress
            type:Organization
      name:Chuanshi Xiao
      affiliation:
            name:The Second Hospital of Shanxi Medical University
            address:
               name:Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, China
               type:PostalAddress
            type:Organization
      name:Jie Du
      affiliation:
            name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases
            address:
               name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
      name:Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, China
      name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
      name:Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, China
      name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
      name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
      name:Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, China
      name:Beijing Anzhen Hospital Affiliated to the Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(178)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

6.99s.

LINK . SPRINGER . COM {}